No breakup, a set of behavioural conditions, and a fifteen-month clock. For a B2B media plan the honest answer is that nothing changes this year — which makes the compliance dates the only part worth diarising.
Judge Leonie Brinkema's remedies decision in the US government's ad tech case landed at the start of September and was read, correctly, as a win for Google. The court declined to order a divestiture of the ad exchange and declined to touch Chrome. What it ordered instead is a set of behavioural conditions that apply globally: AdX must be opened to rival ad servers and to Prebid, Google may not prefer its own tools in auction mechanics, and there are limits on how its buy-side products steer advertisers, with DV360 largely left alone.
The reaction cycle ran for about a week and has mostly ended. That is roughly the right amount of attention for a B2B marketer to give the ruling itself, and roughly the wrong place to stop, because the substance of a behavioural remedy is never in the announcement. It is in the implementation calendar and the monitoring arrangement, and both are unusually long here.
What was actually ordered, and when it bites
Figure 1
Remedy | Reported timeline | What a buyer could in principle verify |
|---|---|---|
AdX opened to rival ad servers | Around 12 months | Whether your publisher partners report real-time access on equal terms |
AdX and DFP connected to Prebid | 12–15 months | The date the connection is live — the clearest single test of compliance |
No self-preferencing in auction mechanics | Ongoing from the order | Almost nothing, without bid-level data you do not currently receive |
Limits on buy-side steering | Ongoing; DV360 largely untouched | Whether your agency's recommendations change, and whether it can say why |
Monitoring and reporting | Three-month intervals | Whatever the monitoring process publishes, if anything reaches buyers |
Two dates and three assertions. The remedies with observable completion events are the ones worth tracking; the rest are compliance questions answered inside a process buyers do not sit in. Timelines as reported in trade coverage of the decision.
The third row is the important one. An anti-self-preferencing obligation is only meaningful to the extent someone outside Google can measure whether preference occurred. That measurement requires auction-level detail that buyers have spent a decade not getting. A remedy you cannot audit does not change your negotiating position; it changes the adjectives in your agency's quarterly review.
Why this lands softly in B2B
Most B2B media budgets are not sitting in open-web display, and have not been for some time. They are in search, in professional social, in a demand-side platform reached through an ABM vendor, in events, in syndication and increasingly in retail-adjacent and trade media environments. Open display shows up as a retargeting line and a low-cost reach line.
Sceptics of the ruling have made much of the point that display's share of impressions fell sharply over the period the case was litigated — from around forty per cent to roughly eleven per cent between 2019 and 2025, on the figures cited in trade coverage. Whatever that says about the remedy's competitive force, it describes B2B buying almost exactly. The channel being reopened is the channel B2B was already leaving.
A remedy that arrives in fifteen months, in the part of the market you have been reducing for five years, is not a media planning event. It is a supplier governance event.
Where it could matter, if it works
Two places, both indirect.
The first is publisher economics. B2B advertisers depend on trade publications, and trade publishers are disproportionately reliant on the open exchange because their audiences are too specialised for scale players to court directly. If genuine header-bidding parity improves publisher yield, the effect on B2B is felt on the supply side first — in which titles survive with an independent commercial model, and at what rate card.
The second is transparency as a precedent. The remedy's only durable gift to buyers would be data: bid-level records that make an auction reconstructable. B2B has a specific use for that which consumer advertising does not. When a campaign promises delivery against senior decision-makers at named accounts, the claim currently rests on a vendor's own reporting. Auction-level evidence is the first mechanism that could make such a claim independently checkable rather than contractually asserted.
Neither of those is ordered. Both are downstream possibilities that depend on how the conditions are implemented — which is why the implementation dates deserve more attention than the verdict did.
What to do with this
Do not re-plan anything.There is no allocation change justified by this decision in the next two quarters. If a partner tells you otherwise, they are selling.
Ask your agency three questions in writing.Which of our spend touches AdX today; what auction-level data can you provide on that spend now; and what will you be able to provide once the Prebid connection is live.
Put the audit right in the renewal, not the brief.Contract language on access to log-level or auction-level data is negotiable at renewal and unobtainable mid-flight. The remedy makes the ask more reasonable than it was last year.
Diarise the Prebid connection.It is the one remedy with a binary, observable completion event. Whether it happens on time is the best available signal about how the rest is going.
Read the supply side, not the buy side.The B2B consequence shows up in which trade titles remain viable and what they charge. That is a media-relationship question, and it is worth asking your key publishers directly.
The longer bet
Behavioural remedies in advertising have a mixed record, and the reason is structural rather than cynical: the conduct is technical, the monitoring is periodic, and the market moves faster than the compliance calendar. Fifteen months from now the distribution of B2B attention will have shifted again — further into assistant-mediated discovery, further into trade and retail media networks, further into first-party audience relationships that never touch an exchange.
That is the strategic fact underneath the legal one. The case was about who controls the plumbing of a market that was already draining. Buyers who spend the next fifteen months improving what they own — audience data, publisher relationships, measurement they can verify — will be in a better position than buyers who spend it waiting to see whether a competitor gets fair access to an exchange.
Sources and notes. Remedies decision of Judge Leonie M. Brinkema in the US Department of Justice's ad tech case against Google, with the opinion reported and unsealed in early September 2026. As reported: divestiture of the ad exchange and of Chrome rejected; behavioural remedies applying globally, including opening AdX to rival ad servers and to Prebid, a prohibition on self-preferencing in auction mechanics, and limits on buy-side steering, with DV360 largely unaffected; implementation timelines of approximately 12 months for rival ad server access and 12–15 months for the Prebid connection, with monitoring on three-month reporting intervals; display's share of impressions cited as falling from around 40% to 11% between 2019 and 2025. All details are drawn from trade coverage (including AdExchanger and Digiday) rather than from the opinion itself — verify against the court record before relying on any specific date or condition. Appeals may alter the position. Journalism, not legal or media-buying advice. Corrections welcome.
